Sudeep Pharma
add_icon

Sudeep Pharma

754.50
-4.10
(-0.54%)
Market Cap
8,521.97 Cr
PE Ratio
49.07
Volume
1,94,981.00
Day High - Low
785.75 - 742.50
52W High-Low
816.35 - 524.05
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
8,521.97 Cr
EPS
15.50
PE Ratio
49.07
PB Ratio
9.68
Book Value
78.21
EBITDA
221.90
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
28.13
Debt to Equity
0.25
Analyst Rating and Forecast
- By Refinitiv from2 analysts
SELL
Analysts have suggested that investors can sell this stock
Buy
Buy0.0 %
0.0 %
Hold
Hold+50.00 %
+50.00 %
Sell
Sell+50.00 %
+50.00 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Sudeep Pharma will attend investor meets on May 28 and June 8, 2026. Discussions will rely on publicly available information.
neutral
Sudeep Pharma has uploaded the audio recording of its Q4FY26 earnings call held on May 22, 2026. The recording is accessible on the company's official website.
neutral
Sudeep Pharma has scheduled a Board of Directors meeting on May 21, 2026, to approve Q4FY26 audited financial results and consider a final dividend for FY2025-26.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,782.20
#1 4,27,609.48
37.09
#1 58,220.10
6.38
#1 11,565
25.80
43.33
6,623.00
1,75,819.84
68.17
10,560.00
8.73
2,520
13.44
49.66
4,420.90
1,49,623.34
68.66
13,886.20
20.34
2,138
-26.91
53.32
1,401.30
1,13,194.31
29.24
27,711.70
-2.46
3,783
-55.32
58.57
1,089.00
1,09,578.88
21.32
26,719.70
13.65
5,242
7.82
71.01
1,278.20
1,06,684.07
25.44
33,593.30
-0.44
3,998
-86.05
45.82
2,267.70
1,03,643.69
#1 19.20
27,487.50
19.98
5,345
#1 87.72
47.04
2,336.10
96,435.39
50.16
14,277.60
12.03
1,750
31.75
47.08
1,462.30
84,930.62
24.27
33,384.70
3.21
3,376
1.99
53.78
1,446.80
78,106.45
86.55
6,812.90
#1 21.03
884
21.18
80.98
Growth Rate
Revenue Growth
25.61 %
Net Income Growth
27.72 %
Cash Flow Change
-25.82 %
ROE
-24.83 %
ROCE
-26.70 %
EBITDA Margin (Avg.)
-15.11 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
81
151
118
161
130
173
179
189
Expenses
52
85
76
99
81
107
112
120
EBITDA
30
65
42
63
49
66
67
69
Operating Profit %
35 %
43 %
34 %
37 %
35 %
34 %
35 %
34 %
Depreciation
3
3
3
3
3
4
4
4
Interest
2
1
1
2
2
2
1
2
Profit Before Tax
26
62
38
58
44
60
62
63
Tax
9
13
9
14
13
13
14
14
Net Profit
17
49
29
44
31
47
48
49
EPS in ₹
4.49
4.49
2.65
4.07
2.84
4.20
4.29
4.38

Balance Sheet

Balance Sheet
2020
2021
2022
2024
2025
2026
Total Assets
131
213
344
514
717
1,175
Fixed Assets
60
68
137
180
189
454
Current Assets
56
100
197
275
424
624
Capital Work in Progress
8
24
8
45
88
178
Investments
0
0
0
0
0
216
Other Assets
63
121
199
289
440
0
Total Equity & Liabilities
131
213
344
514
717
1,175
Current Liabilities
37
80
147
137
175
202
Non Current Liabilities
13
19
34
21
49
75
Total Equity
81
114
163
356
493
883
Reserve & Surplus
80
113
162
355
481
872
Share Capital
1
1
1
1
12
11

Cash Flow

Cash Flow
2020
2021
2022
2024
2025
Net Cash Flow
-0
8
10
4
23
Investing Activities
-23
-40
-38
-49
-79
Operating Activities
10
35
-3
66
49
Financing Activities
12
13
51
-13
53

Share Holding

% Holding
Jun 2025
Nov 2025
Dec 2025
Mar 2026
Promoter
91.07 %
89.36 %
76.15 %
76.15 %
FIIs
0.00 %
0.00 %
1.67 %
1.55 %
DIIs
0.00 %
0.00 %
17.60 %
18.11 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
3.27 %
3.11 %
Others
8.93 %
10.64 %
1.31 %
1.07 %
No of Share Holders
16
26
43,599
36,503

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
19 Dec 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 Dec 2025 698.20 672.95
06 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2026 593.90 618.30
21 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
21 May 2026 634.70 650.10

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript8 days ago
Compliances-Reg.24(A)-Annual Secretarial Compliance9 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 22, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 22, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 21, 2026
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 21, 2026
Submission Of Financial Results For The Year Ended 31St March 2026May 21, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 21St May 2026May 21, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 14, 2026
Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financials For The Fourth Quarter And Year Ended 31St March 2026.May 14, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2026
Closure of Trading WindowMar 26, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 17, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 09, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 07, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2026
Un-Audited Financial Results As On 31.12.2025Feb 06, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 06.02.2026Feb 06, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 02, 2026
Board Meeting Intimation for Approval Of Unaudited Financial Results As On 31St December 2025 Along With Other Business ItemsFeb 02, 2026
Announcement Under Regulation 30 (LODR) - Intimation Of Approval For Purchase Of Rights In Leasehold Land In GIDC By Sudeep Advanced Materials Private Limited A Wholly Owned Subsidiary (WOS) Of The Company.Jan 22, 2026
General UpdateJan 16, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2026
Closure of Trading WindowDec 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeDec 22, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationDec 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 20, 2025
Submission Of Financials As On Quarter And Half Year Ended 30Th September 2025Dec 19, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 19Th December 2025Dec 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 15, 2025
Board Meeting Intimation for Adoption Of Unaudited Financial Results For The Quarter And Half Year Ended On September 30 2025 And Other Business ItemsDec 15, 2025
Intimation Of Unsecured Loan Granted To Sudeep Advanced Materials Private Limited A Wholly Owned Subsidiary (WOS) Of The CompanyDec 09, 2025
Closure of Trading WindowNov 28, 2025
Listing of Equity Shares of Sudeep Pharma LtdNov 28, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Aditya Birla Sun Life Small Cap Fund Direct-Growth
0.48%
0
0.00%
0.01%
Angel One Nifty Total Market Index Fund Direct-Growth
0.01%
0
0.00%
0.00%
Axis Equity Savings Fund Direct-Growth
0.32%
0
0.00%
0.05%
Axis Multi Asset Allocation Direct Plan-Growth
0.14%
0
0.00%
-0.05%
Axis Small Cap Fund Direct-Growth
0.52%
0
0.00%
0.02%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.01%
0
0.00%
0.00%
Bandhan Small Cap Fund Direct-Growth
0.04%
0
0.00%
-0.01%
Edelweiss Equity Savings Fund Direct-Growth
0.36%
0
0.00%
0.04%
Edelweiss Recently Listed IPO Fund Direct-Growth
1.58%
0
0.00%
-0.01%
Groww Nifty Total Market Index Fund Direct-Growth
0.01%
0
0.00%
0.00%
HDFC Innovation Fund Direct-Growth
0.32%
0
0.02%
0.03%
HDFC Manufacturing Fund Direct-Growth
0.60%
0
0.00%
0.04%
ICICI Prudential MNC Fund Direct-Growth
1.22%
0
0.00%
-0.06%
Mirae Asset Healthcare Fund Direct-Growth
0.48%
0
0.00%
0.05%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.01%
0
0.00%
0.00%
Motilal Oswal Large Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Motilal Oswal Nifty Microcap 250 Index Fund Direct-Growth
0.20%
0
0.00%
0.00%
Nippon India Flexi Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Quant Small Cap Fund Direct Plan-Growth
0.03%
0
0.00%
0.00%
SBI Healthcare Opportunities Fund Direct Plan-Growth
2.23%
0
0.00%
0.25%
UTI Healthcare Fund Direct-Growth
1.99%
0
0.00%
-0.14%
WhiteOak Capital Balanced Advantage Fund Direct-Growth
0.09%
0
0.00%
0.01%
WhiteOak Capital Balanced Hybrid Fund Direct-Growth
0.04%
0
0.00%
0.00%
WhiteOak Capital ELSS Tax Saver Fund Direct-Growth
0.18%
0
0.00%
0.01%
WhiteOak Capital Flexi Cap Fund Direct-Growth
0.15%
0
0.00%
0.01%

Technical Indicators

RSI(14)
Neutral
66.22
ATR(14)
Less Volatile
35.52
STOCH(9,6)
Neutral
72.68
STOCH RSI(14)
Overbought
82.49
MACD(12,26)
Bullish
10.17
ADX(14)
Strong Trend
36.88
UO(9)
Bearish
43.92
ROC(12)
Uptrend And Accelerating
16.84
WillR(14)
Neutral
-31.50